A 2023 biotech breakthrough: CRISPR gene-editing therapy offers new hope for 100,000 Americans with sickle cell. Hear from CASGEVY's creators and patient advocates in this episode.
Biotech tackles climate change with innovations, from carbon-neutral facilities to reducing emissions. At COP28, BIO highlighted that biotech is key to climate tech.
Editing Cells Within the Body—a New CRISPR Frontier
CRISPR, biotech's rising star, reached a 2023 milestone with FDA approval for a sickle cell treatment. This episode explores the future of in-body gene editing with two pioneering companies.
Listener takeover: Your Biotech Questions Answered
In this episode, experts answer your questions on GMO safety, personalized medicine, feeding the world by 2050, and what attracts investors to start-ups.
Editing Cells Within the Body—a New CRISPR Frontier
Episode 84 • Apr 23, 2024 • 21 min
With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near future. In this episode we talk with two companies working together on the next generation of CRISPR: editing cells within the body. We discuss the progress and the challenge in making this breakthrough a reality.